Will angiotensin receptor II blockers play a role in epilepsy prevention? Study examines whether ARB therapy is associated with a decreased incidence of new onset epilepsy in patients with hypertension. Health Canada approves two therapies for COVID-19 treatmentSingle-dose Evusheld is now indicated for treating mild/moderate COVID-19 and Actemra IV is now approved for treating COVID-19 in hospitalized adults. Preservative-free eyedrops now available in Canada Alcon's newest product for dry eye clinically demonstrated to provide all-day symptom relief. Drug News—August/September 2022 A review of new launches, new indications, new dosage forms and Health Canada advisories. Drug News—June/July A review of new launches, new indications, new dosage forms and Health Canada advisories. Splitting laxative dose better for colonoscopy polyp detection Researchers suggest abandoning one-dose, day-before bowel preparation regimens Vitamin B12 injection often prescribed inappropriately Study estimates annual cost of inappropriate B12 use to be $45.6 million in Ontario First Previous 37 38 39